Kaia Health’ $26 Million Series B Financing Round


Dentons advised Kaia Health Software GmbH on its Series B financing round.

The financing round was led by Optum Ventures, Idinvest and Capital300, with the participation of existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures, the investment vehicle of golfer Rory McIlroy.

With over 400,000 users, Kaia is the global market leader in digital therapies. The company provides an individual workout schedule for clinically proven therapies, enabling patients with chronic back pain to receive long-term treatment without the physical presence of a doctor or physiotherapist. By means of computer vision technology, the user receives individual suggestions for improvement in the execution of the therapeutic exercises.

Kaia intends to use the funds from the Series B financing round to further develop its digital therapies and to find new solutions for other illnesses such as chronic lung disease COPD in collaboration with experts from various medical disciplines. As a result of the COVID-19 pandemic, Kaia expects further growth in the market for digital therapies.

A Dentons team led by partner Thomas Strassner (Picture) provided Kaia with legal advice on all aspects of the financing round. He was supported by Alexander Reiner (Counsel), Anja Stalter and Michael Singer (both Senior Associate), Pablo Albrecht (Associate, all Corporate/M&A, Private Equity/Venture Capital), and Christine Herkommer (Senior Associate, Corporate/Data Protection).

Involved fees earner: Pablo Albrecht – Dentons; Christine Herkommer – Dentons; Alexander Reiner – Dentons; Michael Singer – Dentons; Anja Stalter – Dentons; Thomas Strassner – Dentons;

Law Firms: Dentons;

Clients: Kaia Health;